| NOBEL Pharma Schweiz AG - Rivaroxaban NOBEL vascular 2.5 mg, Filmtabletten | | 68021 | | 01 | | Rivaroxaban NOBEL vascular 2.5 mg | | Filmtabletten | | B01AF01 | | Rivaroxaban | | 05.05.2022 | | |
| | Composition | | rivaroxabanum 2.5 mg, mannitolum, carmellosum natricum conexum, hypromellosum, natrii laurilsulfas, cellulosum microcristallinum, magnesii stearas, Überzug: hypromellosum, macrogola, E 171, E 172 (flavum) pro compresso obducto corresp. natrium 0.33 mg. | | Packungsbestandteile | | Coated tablets | | | | Active Agent | Dose |
|---|
| Rivaroxabanum | 2.5 mg |
| | | | Inactive agents | | additional_information |
|---|
| (Flavum) pro Compresso Obducto | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | Überzug | | Macrogola | | | | Magnesii Stearas | | | | Mannitol | | | | Natrii Laurilsulfas | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 56 | PR | PR | B | | Yes | | 002 | 196 | PR | PR | B | | Yes |
|
|
